Adaptable & Hemodynamic Human Endothelial Cells for Immunotherapeutic Organoid Tumor Targeting
Time: 1:55 pm
day: Day 1 Track A PM
Details:
- Exploring the integration of multiple cell types, including immune cells and stromal cells, to create more physiologically relevant models
- Discussing how this device can be implemented for drug screening purposes and to uncover the molecular basis of tumor resistance and metastasis
- Showcasing a case study illustrating how this device provided critical insights into CAR-T development, and potential combination strategies
